Ticker

VRDN

Viridian Therapeutics, Inc.

9 catalysts on file

VRDN

Viridian Therapeutics, Inc.

Phase 3 Confirmed

elegrobart

thyroid eye disease (TED)

108d ago May 5, 2026

SEC 8-K verified 2mo ago

Countdown card →

VRDN

Viridian Therapeutics, Inc.

Approval Confirmed

Lumvoa

thyroid eye disease

53d ago Jun 29, 2026

SEC 8-K verified 2mo ago

Countdown card →

VRDN

Viridian Therapeutics, Inc.

PDUFA Confirmed

veligrotug

thyroid eye disease (TED)

52d ago Jun 30, 2026

SEC 8-K verified 2mo ago

Countdown card →

VRDN

Viridian Therapeutics, Inc.

Phase 3 Confirmed

elegrobart (VRDN-003)

active TED

52d ago ~ Jun 30, 2026

SEC 8-K verified 2mo ago

Countdown card →

VRDN

Viridian Therapeutics, Inc.

Phase 1 Confirmed

VRDN-008

T-minus 132 days ~ Dec 31, 2026

SEC 8-K verified 2mo ago

Countdown card →

VRDN

Viridian Therapeutics, Inc.

Catalyst Confirmed

TSHR program

thyroid eye disease (TED) and Graves’ disease

T-minus 132 days ~ Dec 31, 2026

SEC 8-K verified 2mo ago

Countdown card →

VRDN

Viridian Therapeutics, Inc.

Catalyst AI-extracted

Undisclosed program

T-minus 132 days ~ Dec 31, 2026

SEC 8-K verified 2mo ago

Countdown card →

VRDN

Viridian Therapeutics, Inc.

Catalyst Confirmed

elegrobart

thyroid eye disease (TED)

T-minus 222 days ~ Mar 31, 2027

SEC 8-K verified 2mo ago

Countdown card →

VRDN

Viridian Therapeutics, Inc.

Phase 3 Confirmed

Lumvoa

thyroid eye disease

Date TBD Date TBD

SEC 8-K verified 2mo ago

Countdown card →